Sharon M Weber, MD, FACS


  • Chief, Division of Surgical Oncology
  • Medical Director of Surgical Oncology, UW Carbone Cancer Center
  • Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology
Clinic: (608) 263-7502

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Box 7375 Clinical Science Center
Madison, Wisconsin 53792-3284


  • MD, University of Wisconsin Medical School, Madison, WI, 1993
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors. Dr. Weber’s research interests also include mixed methods evaluation of risk factors for readmission using a systems engineering approach with a focus on the transition of care and outcomes research evaluating preoperative predictors of postoperative complications.

Recent Publications

  • A telephone-based surgical transitional care program with improved patient satisfaction scores and fiscal neutrality.
    Schreiter NA, Fisher A, Barrett JR, Acher A, Sell L, Edwards D, Leverson G, Joachim A, Weber SM, Abbott DE
    Surgery 2020 Oct 19;
    [PubMed ID: 33092810]

  • Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
    Aiken TJ, Stahl CC, Schwartz PB, Barrett J, Acher AW, Lemaster D, Leverson G, Weber S, Neuman H, Abbott DE
    J Surg Oncol 2020 Sep 16;
    [PubMed ID: 32939750]

  • A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer.
    Witt JS, Kuczmarska-Haas A, Lubner M, Reeder SB, Cho SY, Minter R, Weber S, Ronnekleiv-Kelly S, Abbott D, LoConte N, Mulkerin DL, Lubner SJ, Uboha NV, Deming D, Ritter MA, Mohindra P, Bassetti MF
    Int J Radiat Oncol Biol Phys 2020 Sep 14;
    [PubMed ID: 32942002]

  • Emerging pathways for precision medicine in management of cholangiocarcinoma.
    Rahnemai-Azar AA, Abbasi A, Acher AW, Weber SM, Pawlik TM
    Surg Oncol 2020 Aug 12; 35: 47-55
    [PubMed ID: 32827952]

  • Early vs Late Readmissions in Pancreaticoduodenectomy Patients: Recognizing Comprehensive Episodic Cost to Help Guide Bundled Payment Plans and Hospital Resource Allocation.
    Acher AW, Barrett JR, Schwartz PB, Stahl C, Aiken T, Ronnekleiv-Kelly S, Minter RM, Leverson G, Weber S, Abbott DE
    J Gastrointest Surg 2020 Jul 15;
    [PubMed ID: 32671797]

All Publications on PubMed